Cretap Tablet 20 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
MFDS item code 202001672 · Approved 2020.03.11
This product's status changed to Approval withdrawn on 2024.12.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when diet and exercise alone are inadequate to control hypercholesterolemia and mixed dyslipidemia. It is also helpful as an adjunct to diet and other therapies for patients with familial hypercholesterolemia. It effectively lowers total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis. It can also be used as an adjunct to diet in pediatric patients with heterozygous familial hypercholesterolemia. Additionally, it provides benefits for patients with primary dysbetalipoproteinemia and reduces the risk of cardiovascular diseases. Specifically, it has shown efficacy in reducing the risks of stroke, myocardial infarction, and arterial revascularization. This drug is used to improve blood lipid levels and maintain cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication, and continue it throughout the treatment period. This medication may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering this medication at 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. It should not be administered to patients who are allergic to this drug, those with serious liver problems, muscle diseases, or severe kidney impairment. Pregnant or breastfeeding women, and women who may become pregnant should only use this medication if they are fully aware of the potential risks to the fetus and have a high likelihood of not becoming pregnant. Furthermore, patients who are prone to muscle disorders or rhabdomyolysis should be particularly cautious, as high doses of this medication are contraindicated. This medication contains lactose and should not be given to patients with lactose intolerance or related genetic diseases. Patients with a history of liver disease or those who consume excessive amounts of alcohol, as well as those with hypothyroidism, should be thoroughly evaluated before taking this medication and should have regular liver function tests. If symptoms of muscle pain or weakness appear, they should immediately inform healthcare personnel, and if necessary, blood tests should be conducted to check for muscle damage. This medication may rarely cause serious skin reactions or liver damage, so if symptoms such as a skin rash or jaundice occur, it should be stopped immediately and a doctor consulted. Additionally, this medication may interact with many drugs, so if other medications are being taken, it is essential to inform healthcare personnel, particularly when used in conjunction with certain antiviral agents, antifungals, immunosuppressants, and fibrate drugs. It should not be used during pregnancy or breastfeeding, and women who may become pregnant must use appropriate contraceptive methods. In case of overdose, as there is no specific antidote, symptomatic treatment should be received while monitoring liver function and muscle condition. Finally, dizziness or muscle pain may occur while taking this medication, so caution is needed when driving or operating machinery.
Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, AST elevation, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. By storing it this way, the efficacy and safety of the medication can be preserved for a long time.
Pink circular film-coated tablet
28 tablets (14 tablets/PTP packaging x 2), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.